Big moves aren’t loud they’re strategic.
DELEX signing with Invokution (India) in Q1 2025 taps directly into one of the fastest-growing medical device markets in the world.
This is expansion with purpose.
#BNCM #DELEX #India #OTC #OTCMarkets #Pharma #Pharamaceuticals

$BNCM / $DELEX is set to launch Receptal in the U.S. by February 2025, bringing Amsino’s proven closed-suction tech to hospitals nationwide.
Execution > promises — and this is just the beginning.
#OTC #Investing #HealthcareInnovation #OTC #MedTech #Receptal #Amsino #BNCM #DELEX #GrowthMode #Feb2025

bncm.us #BNCM
$BNCM is stepping into a new era of innovation and market expansion.
With a growing pipeline, international partnerships, and real execution across healthcare + tech, the momentum is building fast.

$BNCM is aligning catalysts, partnerships, and expansion strategies that position it for a stronger footprint across multiple markets. As DELEX scales, the story is becoming clearer: real products, real execution, efficiency. The next wave of growth is forming.
#BNCM #DELEX #OTC #OTCMarket bncm.us

The U.S. medical market rewards one thing: solutions that work. Receptal is already a proven closed-suction system globally and now it enters a $7B+ U.S. hospital suction & fluid management market.
#BNCM #DELEX #HealthcareInnovation #OTC #MedTech #Receptal #Amsino #BNCM #DELEX #GrowthMode #Feb2025

Investors check bncm.us and delexpharma.com
#bncm #delex #otc #otcmarkets

@angeloalayan.bsky.social check out #BNCM